Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 27, 2013View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventDec 24, 2013View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 23, 2013View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 13, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 11, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 11, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 11, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 9, 2013View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventDec 6, 2013View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesDec 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 18, 2013View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GNov 12, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 7, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 5, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 4, 2013View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionOct 28, 2013View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventOct 24, 2013View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 18, 2013View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventOct 15, 2013View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 15, 2013View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventOct 11, 2013View HTMLDownload DOCDownload PDFDownload XLS
FWPFree Writing ProspectusOct 9, 2013View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Oct 9, 2013View HTMLDownload DOCDownload PDFDownload XLS
S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersOct 7, 2013View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Oct 7, 2013View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-100      101-125      126-150      151-153

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information